An MIT spin-off company called Sherlock Biosciences has gotten FDA approval to begin using its CRISPR-based COVID-19 test, which promises to be faster and easy to perform without access to a full lab.

New CRISPR approach: HKUST scientists created a DNA-guided CRISPR-Cas12a system that targets RNA, overturning the traditional ...

Thanks to CRISPR, this at-home COVID-19 test is both fast and accurate Sherlock Biosciences’ first-ever use of CRISPR in a diagnostic has huge potential for at-home COVID-19 testing and beyond. CRISPR ...

A research team led by Prof. Hsing I-Ming, Professor of the Department of Chemical and Biological Engineering (CBE) at The ...

Sherlock Biosciences Inc. is on the case of the missing tests – the lack of diagnostic testing for sexually transmitted infections, that is. Sherlock’s over-the-counter molecular, disposable tests ...